News 20 Lug 2022 Forty51 closes first fund totaling 43 million US dollars A new Basel-based venture fund, Forty51 Ventures I, has raised a total of 43 million US dollars following a first fund closing. Forty51 invests i...
News 14 Set 2021 Kinarus secures capital commitment of 57 million Swiss francs The biopharmaceutical company Kinarus has signed a capital commitment of up to 57 million Swiss francs with the investment group GEM. This should...